Last summer, the Supreme Court issued its decision in Association for Molecular Pathology, et al. v. US Patent and Trademark Office, Myriad Genetics, et al, S. Ct. 2107 (2013), regarding whether human genes are patentable. Although the Court held that isolated, naturally-occurring DNA segments are unpatentable products of nature, that is not the end of the story for the biotech industry. The Court also held that non-naturally occurring DNA segments are patentable.
This course explores the Courts’ decision and its effect on the current set of court challenges: the patentability of DNA segments in the context of primers (DNA strands that jumpstart DNA replication) and probes (which are primers with an attachment). The course also evaluates the new US Patent Office Guidelines issued on March 4, 2014.
I. Understand the Supreme Court decision in Association for Molecular Pathology, et al. v. US Patent and Trademark Office, Myriad Genetics, et al, S. Ct. 2107 (2013)
II. Grasp the patentability of DNA segments in the context of primers (DNA strands that jumpstart DNA replication) and probes (which are primers with an attachment)
III. Evaluate the new US Patent Office Guidelines issued on March 4, 2014
This course is pre-approved for CLE credit in the following states. If your state is not listed, contact support for more information on how to receive credit
Successful, profitable businesses share certain characteristics: immediately recognizable brands, desirable products or services, and a strategic plan which minimizes legal risks. As co-chair of the Intellectual Property Group at Tarter Krinsky & Drogin, Amy B. Goldsmith partners with clients to provide practical legal advice and connections to grow their businesses. A strategic advisor, she guides clients in all stages of their development from idea conception and protection, to funding, manufacturing and enforcement.
She will advise you whether your trademark is available in the United States and globally, if patents should be a part of your strategy, and if your design team’s new product shares too many features of the competition’s copyrighted bestseller. She will design contracts that make sense. Amy will also guide you through the clearance process, whether the subject matter is books, movies or live action. If a dispute is on the horizon, she will be by your side until a fair resolution is reached.
Amy protects the global interests of national and international clients in a wide variety of industries, including fashion, cosmetics, pet products, publishing, medical devices, exercise equipment, web-based business applications and telecommunications platforms, and consumer and designer goods.
She is a Vice President of the New York Women's Bar Association. She is also a member of the American Bar Association and the International Trademark Association (INTA) and is on the Board of Directors of Savvy Ladies, a non-profit whose mission is to educate women to be financially savvy. Amy also was a speaker at and served on the Advisory Board for TedxTimesSquare.
Before joining Tarter Krinsky & Drogin, Amy was a partner at Gottlieb, Rackman & Reisman, P.C.
Very nice detailed slides.
Interesting, although niche topic.
..clear voice need better background and more slides on biology, the cell and how the DNA is formed.
Very knowledgeable lecturer.
one of the best presenters in recent memory